fifty-five patients with metastatic carcinomas of unknown primary site ( 50 adenocarcinomas ) were randomized , after stratification , to treatment with either mitomycin and doxorubicin ( ma ) or mitomycin , doxorubicin , and cisplatin ( map ) .
C0001418
adenocarcinomas
C0002475
mitomycin